Injectable Bioactive Composites vs RMGI for Proximal Cavities in Primary Molars

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
This randomized clinical trial aims to evaluate and compare the clinical performance of injectable bioactive composite (Beautifil Flow Plus X, Shofu) versus Resin Modified Glass Ionomer (RMGI) in restoring proximal cavities (Class II) in primary molars of children aged 3-8 years over a 12-month follow-up period, using revised FDI criteria.
Epistemonikos ID: 4365a9d1a43c22310569104bc72764caac102d0c
First added on: May 02, 2026